trial · primary record
tocilizumab
Heart Transplant
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 385 |
| Primary completion | 2025-03-25 |
| Primary endpoint | Percentage of Participants Positive for Event of dnDSA, ACR, AMR, Hemodynamic Compromise, Death or Re-Transplantation |
| Registry ID | NCT03644667 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:10.789Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03644667
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.